Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Driving the next generation of endocrinology care. See our social community guidelines: https://crinetics.com/social-media-community-guidelines/

We are a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Driven by the belief that no one should be defined by their disease, we’re transforming endocrine care to significantly improve the lives of patients, caregivers, and loved ones. As the premier, endocrine-rooted pharmaceutical company, we’re shaping the future of treatment, empowering individuals to live beyond their condition, and thrive. Learn more at www.crinetics.com.

01/12/2026

We’re excited to join fellow leaders in the biotech and healthcare community at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Crinetics will highlight our significant achievements in 2025, share our outlook for 2026 and lay out our vision for 2030 during our corporate presentation on Tuesday, January 13 at 9:45 a.m. PT. Read more: https://bit.ly/49s6ikF

Celebrating where it all began! This week marks the 16th anniversary of Crinetics’ first lab, the spark that shaped our ...
01/06/2026

Celebrating where it all began! This week marks the 16th anniversary of Crinetics’ first lab, the spark that shaped our discovery engine and defined who we are. Built by scientists and endocrinologists, we’ve grown from a few benches and big ideas into a global company advancing innovative therapies for people with endocrine diseases. Swipe to see photos from our early days.

This year, we joined patient advocates, caregivers, and healthcare leaders around a shared goal: helping people with ser...
12/29/2025

This year, we joined patient advocates, caregivers, and healthcare leaders around a shared goal: helping people with serious endocrine diseases live better lives. Swipe to see some of the highlights from our year of partnership and purpose.

12/19/2025

Say hello to the newest addition to our pack! Meet Katniss, our Chief Legal Officer Garlan Adams’ adorable bulldog puppy! She’s already aced new hire orientation making the rounds, melting hearts, and reminding us that every day is better with puppy energy in the mix.

We’re proud to be a dog-friendly workplace where science and smiles go hand-in-paw: https://crinetics.com/careers/

Serving smiles and meals with Mama's Kitchen! The Crinetics team rolled up our sleeves to spend the day helping prepare ...
12/16/2025

Serving smiles and meals with Mama's Kitchen! The Crinetics team rolled up our sleeves to spend the day helping prepare meals at Mama’s Kitchen. We’re proud to support an incredible organization making a difference right here in San Diego.

The first patient has been dosed in CALM-CAH, a pivotal study of our investigational candidate for classic congenital ad...
12/11/2025

The first patient has been dosed in CALM-CAH, a pivotal study of our investigational candidate for classic congenital adrenal hyperplasia in adults – an important step forward in our mission to advance care for those living with serious endocrine diseases. 🔗 https://bit.ly/4rNXxKl

We’re proud to announce the first patient has been dosed in our Phase 1/2 trial evaluating our novel nonpeptide drug con...
12/03/2025

We’re proud to announce the first patient has been dosed in our Phase 1/2 trial evaluating our novel nonpeptide drug conjugate candidate CRN09682 for the treatment of neuroendocrine tumors and other somatostatin receptor 2-expressing tumors. Read the full announcement: https://bit.ly/3Mdcx48

Crinetics announces the randomization of the first patient in a Phase 3 trial of an investigational treatment being stud...
11/20/2025

Crinetics announces the randomization of the first patient in a Phase 3 trial of an investigational treatment being studied in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. Read more: https://bit.ly/3X6kKcn

11/11/2025

This Veterans Day, we proudly recognize our very own Bill Branch, who served 26 years in the U.S. Marine Corps Reserve, leading with trust, teamwork, and purpose. Today, he brings that same dedication and leadership to his role as Director of Federal & State Government Accounts at Crinetics.

We salute Bill and all those who’ve served for their strength, sacrifice, and commitment to something greater than themselves.

This World NETs Cancer Day, we reaffirm our commitment to people living with neuroendocrine tumors (NETs). We were proud...
11/10/2025

This World NETs Cancer Day, we reaffirm our commitment to people living with neuroendocrine tumors (NETs). We were proud to meet with clinical leaders and patient advocacy partners in the NETs space at the recent NANETs meeting to explore how we can continue advancing science for those impacted by NETs. Learn more about how we’re driving innovating in this space: https://bit.ly/3XbsFVK

11/01/2025

Many people have never heard of acromegaly, and even fewer understand what it’s really like to live with it. We asked people living with acromegaly what they wish others knew about the condition. Here’s what they shared ⬇️

10/08/2025

Say hello to Guapo! 🐾 Living up to his name, Guapo is Torrie Plata’s handsome pup who loves bringing joy, cuddles, and a little extra sunshine to the office. We’re proud to be a workplace where dogs are part of our pack, wagging tails included: https://bit.ly/3BmigiR

Address

6055 Lusk Boulevard
San Diego, CA
92121

Alerts

Be the first to know and let us send you an email when Crinetics Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Crinetics Pharmaceuticals:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram